A major limitation of clinical PI3K inhibition is the lack of apoptotic induction that leads to tumor clearance, as PI3K monotherapy is primarily associated with a cytostatic effect induced by G1 arrest (19). This evidence concerns the gene PIK3CA and neoplasm.